Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Mirabegron is a non-peptide, small-molecule selective β3-adrenergic receptor agonist FDA-approved in 2012 for overactive bladder. It is also sold as unregulated 'research use only' powder by fine-chemical vendors, despite being a prescription pharmaceutical. Investigational metabolic research has used a dose above the approved regimen to study brown adipose tissue activation—an off-label, non-approved use. Mirabegron is pharmacologically distinct from WADA-prohibited β2-agonists, though its doping status remains unconfirmed against primary WADA text.
Verified purity per dollar — the cheapest that's actually been tested
No prices found for Mirabegron (YM-178).
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Kimera Chems has the lowest single-vial Mirabegron (YM-178) price at $0.015/mg among 2 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower.
What is the price range for Mirabegron (YM-178)?
Research-grade Mirabegron (YM-178) is listed at $0.015/mg from 1 verified source on Disclosed Labs.
How are Mirabegron (YM-178) prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Mirabegron is an FDA-approved drug with extensive human data, not a novel research chemical. Approved adult dosing is 25 mg once daily, increased to 50 mg after 4–8 weeks for overactive bladder. A registered clinical trial (NCT04823442) used 100 mg/day for 4 weeks in 14 healthy women, reporting increased brown adipose tissue activity/volume, HDL cholesterol, insulin sensitivity, and resting energy expenditure with no change in body weight or fat mass (O'Mara et al., J Clin Invest 2020, PMID 31961826)—an open-label study without placebo control. Rat studies confirmed selective β3-adrenoceptor agonist activity with bladder-relaxant effects (Hatanaka et al., 2013, PMID 23239087). Ex vivo porcine ureter studies found mirabegron reduced contractility partly via α1-adrenoceptor antagonism, complicating a pure β3-selectivity profile at the ureter (PMC9192402).
This platform provides informational tools only, not medical advice.
Prices verified as of July 2026. Actual prices may vary. For research use only.
Disclosed Labs